c
 

  

IA Tumor confined to the vulva or perineum, ” 2cm in size with stromal invasion ” 1mm,
negative nodes

IB Tumor confined to the vulva or perineum, > 2cm in size or with stromal invasion > 1mm,
negative nodes

II Tumor of any size with adjacent spread (1/3 lower urethra, 1/3 lower vagina, anus),
negative nodes

IIIA Tumor of any size with positive inguino-femoral lymph nodes

(i) 1 lymph node metastasis greater than or equal to 5 mm

(ii) 1-2 lymph node metastasis(es) of less than 5 mm

IIIB (i) 2 or more lymph nodes metastases greater than or equal to 5 mm

(ii) 3 or more lymph nodes metastases less than 5 mm

IIIC Positive node(s) with extracapsular spread

IVA (i) Tumor invades other regional structures (2/3 upper urethra, 2/3 upper vagina),
bladder mucosa, rectal mucosa, or fixed to pelvic bone

(ii) Fixed or ulcerated inguino-femoral lymph nodes

IVB Any distant metastasis including pelvic lymph nodes

c
 
c


IA1 Confined to the cervix, diagnosed only by microscopy with invasion of < 3 mm in depth
and lateral spread < 7 mm

IA2 Confined to the cervix, diagnosed with microscopy with invasion of > 3 mm and < 5
mm with lateral spread < 7mm

IB1 Clinically visible lesion or greater than A2, < 4 cm in greatest dimension

IB2 Clinically visible lesion, > 4 cm in greatest dimension

IIA1 Involvement of the upper two-thirds of the vagina, without parametrial invasion, < 4
cm in greatest dimension

IIA2 > 4 cm in greatest dimension

IIB With parametrial involvement

IIIA/B Unchanged

IVA/B Unchanged
c
 

 

IA Tumor confined to the uterus, no or < ½ myometrial invasion

IB Tumor confined to the uterus, > ½ myometrial invasion

II Cervical stromal invasion, but not beyond uterus

IIIA Tumor invades serosa or adnexa

IIIB Vaginal and/or parametrial involvement

IIIC1 Pelvic node involvement

IIIC2 Para-aortic involvement

IVA Tumor invasion bladder and/or bowel mucosa

IVB Distant metastases including abdominal metastases and/or inguinal lymph nodes

Uterine sarcomas were staged previously as endometrial cancers, which did not reflect
clinical behavior. Therefore, a new corpus sarcoma staging system was developed based on
the criteria used in other soft tissue sarcomas.[2] This is described as a best guess staging
system, so data will need to be collected and evaluated for further revision.

 

 
 
 
 
  

 

IA Tumor limited to uterus < 5 cm

IB Tumor limited to uterus > 5 cm

IIA Tumor extends to the pelvis, adnexal involvement

IIB Tumor extends to extra-uterine pelvic tissue

IIIA Tumor invades abdominal tissues, one site

IIIB More than one site

IIIC Metastasis to pelvic and/or para-aortic lymph nodes

IVA Tumor invades bladder and/or rectum

IVB Distant metastasis

Adenosarcoma Stage I Differs from Other Uterine Sarcomas

IA Tumor limited to endometrium/endocervix

IB Invasion to < ½ myometrium

IB Invasion to > ½ myometrium?